Sunmax Biotechnology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of biomedical-grade collagen and related products in Taiwan, Mainland China, and internationally. It offers collagen dermal filler sets, such as Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO injectable collagen gel with lidocaine. The company was founded in 2001 and is based in Tainan City, Taiwan.
Frequently asked questions
What sector does Sunmax Biotechnology Co Ltd (4728) operate in?
Sunmax Biotechnology Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Sunmax Biotechnology Co Ltd (4728) current stock price?
As of the latest data, Sunmax Biotechnology Co Ltd stock price is NT$385.50, with a previous close of NT$385.50.
What is Sunmax Biotechnology Co Ltd (4728) current market capitalization?
Sunmax Biotechnology Co Ltd market cap is approximately 21.00 billion.
What is Sunmax Biotechnology Co Ltd (4728) Earnings Per Share (EPS)?
The trailing EPS is NT$13.27.
What is Sunmax Biotechnology Co Ltd (4728) Price-to-Earnings (P/E) ratio?
Sunmax Biotechnology Co Ltd current P/E ratio is 29.05.
Does Sunmax Biotechnology Co Ltd (4728) pay dividends?
Yes. Sunmax Biotechnology Co Ltd pays annual dividends with an annualized yield of 3.14% and an estimated annual payout of NT$12.10 per share.
When is the next ex-dividend date for Sunmax Biotechnology Co Ltd (4728)?
The next ex-dividend date is scheduled for March 31, 2027.
What is Sunmax Biotechnology Co Ltd (4728) beta (volatility) score?
Sunmax Biotechnology Co Ltd has a beta of -0.127, indicating lower volatility than the overall market.